Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
CAR-NK cells may represent a valuable tool, complementary to CAR-T cells, in adoptive immunotherapy of leukemia and solid tumors. However, gene transfer to human NK cells is a challenging task, particularly with non-virus-based techniques. Here, we describe a new procedure allowing efficient electro...
Main Authors: | Tiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, Concetta Quintarelli, Biagio De Angelis, Nicola Tumino, Francesca Besi, Claudia Cantoni, Franco Locatelli, Paola Vacca, Lorenzo Moretta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00957/full |
Similar Items
-
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
by: Concetta Quintarelli, et al.
Published: (2021-06-01) -
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
by: Marsha Pellegrino, et al.
Published: (2021-12-01) -
Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
by: Paula Schmidt, et al.
Published: (2021-01-01) -
Optimized DNA electroporation for primary human T cell engineering
by: Zhang Zhang, et al.
Published: (2018-01-01) -
Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells
by: Iva Kaštánková, et al.
Published: (2021-12-01)